Earnings Call Insights: Xeris Biopharma (XERS) Q2 2026 Management View – Chairman & CEO John Shannon said, “The second quarter was another record-breaking quarter for Xeris” and reported that “Total revenue reached $92 million with net product revenue of $91 million,…
presenting 34% growth year-over-year,” adding that management is “raising the bottom Seeking Alpha’s Disclaimer: This article was automatically generated by an AI tool based on content available on the Seeking Alpha website, and has not been curated or reviewed by humans. Due to inherent limitations in using AI-based tools, the accuracy, completeness, or timeliness of such articles cannot be guaranteed
This article is intended for informational purposes only. Seeking Alpha does not take account of your objectives or your financial situation and does not offer any personalized investment advice. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank